93 related articles for article (PubMed ID: 19007367)
21. Coumarin plus cimetidine: yet another angle for therapy of renal cell carcinoma.
Kirkwood JM; Ernstoff MS
J Clin Oncol; 1987 Jun; 5(6):836-7. PubMed ID: 3585440
[No Abstract] [Full Text] [Related]
22. Adjuvant therapy in pediatric patients with completely resected renal cell carcinoma.
Geller JI; Dome JS
Pediatr Blood Cancer; 2006 Apr; 46(4):527. PubMed ID: 16365852
[No Abstract] [Full Text] [Related]
23. Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma.
Chapman AE; Goldstein LJ
Semin Oncol; 1995 Feb; 22(1):17-28. PubMed ID: 7855615
[No Abstract] [Full Text] [Related]
24. In focus: bevacizumab for renal cell carcinoma.
Clin Adv Hematol Oncol; 2005 Jan; 3(1):68-9. PubMed ID: 16166971
[No Abstract] [Full Text] [Related]
25. Chemotherapy for advanced renal-cell carcinoma: 1983-1993.
Yagoda A; Abi-Rached B; Petrylak D
Semin Oncol; 1995 Feb; 22(1):42-60. PubMed ID: 7855619
[No Abstract] [Full Text] [Related]
26. Immunochemotherapy of metastatic renal cell carcinoma: report of 28 cases.
Wang HJ; Chen HX; Li HZ
Chin Med J (Engl); 2005 Jan; 118(2):172-3. PubMed ID: 15667805
[No Abstract] [Full Text] [Related]
27. [A combined chemo-endocrine therapy of advanced renal cell carcinoma].
Wada T; Yasutomi M; Abe T; Wada A
Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2294-8. PubMed ID: 3128617
[No Abstract] [Full Text] [Related]
28. Combination therapy in patients with metastatic renal cell carcinoma.
Escudier BJ
Clin Adv Hematol Oncol; 2010 Oct; 8(10):665-6. PubMed ID: 21317861
[No Abstract] [Full Text] [Related]
29. Prognostic factors in cytokine-refractory renal cell carcinoma treated with irinotecan, Cisplatin, and mitomycin chemotherapy.
Shamash J; Powles T; Wilson P; Ansell W; Oliver T
J Clin Oncol; 2005 Feb; 23(6):1323-5. PubMed ID: 15718335
[No Abstract] [Full Text] [Related]
30. Prolonged survival in renal transplant recipient with advanced renal cell carcinoma by everolimus and sorafenib.
Ruangkanchanasetr P; Kanjanapayak B; Jungmeechoke K
Nephrology (Carlton); 2011 Jan; 16(1):118-9. PubMed ID: 21175989
[No Abstract] [Full Text] [Related]
31. The Authors Respond.
Hansen RN; Hackshaw MD; Sullivan SD; Ramsey SD
J Manag Care Spec Pharm; 2015 Sep; 21(9):844. PubMed ID: 26536677
[No Abstract] [Full Text] [Related]
32. Treatment of recurrent or metastatic renal cell carcinoma.
Shah RN; Ahmad T; Eisen TG
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1069-80. PubMed ID: 15606334
[TBL] [Abstract][Full Text] [Related]
33. Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB).
Sorio R; Galligioni E; Crivellari D; Talamini R; Monfardini S
Ann Oncol; 1995 Mar; 6(3):306-7. PubMed ID: 7612500
[No Abstract] [Full Text] [Related]
34. New therapeutic options for renal cell carcinoma.
Stadler W
Clin Adv Hematol Oncol; 2006 Jun; 4(6):429-30. PubMed ID: 16981664
[No Abstract] [Full Text] [Related]
35. New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.
Isaacs WB; Isaacs JT; Kyprianou N; Burgers JK; Alexander RB; Partin AW; Mohler JL; Marshall FF; Coffey DS
Eur Urol; 1990; 18 Suppl 2():33-5. PubMed ID: 2226604
[No Abstract] [Full Text] [Related]
36. Immunotherapy and prognostic factors.
Fumagalli LA; Brivio F
J Clin Oncol; 2006 Sep; 24(25):4218-9; author reply 4219-20. PubMed ID: 16943541
[No Abstract] [Full Text] [Related]
37. [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Nakagami Y; Lin TT; Ito H; Hirasawa S; Tannawa K; Fujioka Y; Ogawa H; Tanaka K; Yamada N; Ishii Y
Hinyokika Kiyo; 1987 Oct; 33(10):1728-32. PubMed ID: 3128071
[TBL] [Abstract][Full Text] [Related]
38. Renal cell carcinoma: trying but failing to improve the only curative therapy.
Acquavella N; Fojo T
J Immunother; 2013; 36(9):459-61. PubMed ID: 24145356
[No Abstract] [Full Text] [Related]
39. Access to targeted therapies in renal cell cancer.
Jones R; DeSantis M
Semin Oncol; 2013 Aug; 40(4):521-8. PubMed ID: 23972716
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of established human renal cell carcinoma--experimental treatment with interferon and UFT].
Onishi T; Iizuka N; Suzuki M; Mori Y; Kondo I; Nakada J; Masuda F; Machida T
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1498-502. PubMed ID: 3141533
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
